4:01pm ET
Investing
Apple, Procter & Gamble Sink the DJIA Thursday
Apple, P&G, Johnson & Johnson, and Verizon led the DJIA lower on Thursday.
JNJ Coverage Page 52
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson, 3M, Intercept Pharmaceutical and AutoZone.
1:35pm ET
Health and Healthcare
Why Pfizer Is Pushing the Dow to All-Time Highs
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
7:15am ET
Health and Healthcare
Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
8:50am ET
Health and Healthcare
Achillion Pharma Slides After Hep C Deal Is Terminated
Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration agreement with Janssen had been terminated.
Chris Lange 4:01pm ET
Investing
Johnson & Johnson, Disney Lead DJIA Lower Wednesday
Johnson & Johnson, Cisco Systems, Disney, and Caterpillar led the DJIA downward on Wednesday.
9:04am ET
Investing
10 Companies with the Biggest 2016 Share Buybacks
Companies included on the S&P 500 index bought back more than $500 billion in stock last year and have bought back more than $4 trillion in shares since 2008.
9:00am ET
Technology
Amazon: The Devil You Know and the Devil You Don’t
One thing investors wanted to hear on conference calls this earnings season was how companies are responding to Amazon. One industry that escaped such queries was defense, but that may have been…
4:01pm ET
Investing
Merck, DuPont Lead Dow Lower on Tuesday
Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes before the closing bell.
1:20pm ET
Health and Healthcare
Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease
A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its approval of Imbruvica for the treatment of adult patients with chronic graft…
4:01pm ET
Investing
GE, Nike Guide DJIA Down on Monday
General Electric, Nike, Home Depot, and Johnson & Johnson led the DJIA lower Monday.
9:16am ET
Investing
Top Analyst Upgrades & Downgrades: American Superconductor, Chipotle, Groupon, J&J, Juniper, Occidental, Wells Fargo and Many More
Stocks have pulled back a tad from all-time highs, and the market indexes were indicated to have a slight drop on Friday morning. Still, indexes remain right at all time highs and…
8:37am ET
Health and Healthcare
Why Credit Suisse Prefers Johnson & Johnson Over Pfizer
Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) in a close second.…
9:24am ET
Investing
Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More
Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes all remain just under all-time highs. Even though this bull market may…
9:58am ET
Health and Healthcare
Johnson & Johnson Shares Slip Following Mixed Earnings
Johnson & Johnson (NYSE: JNJ) released its fiscal second-quarter earnings report before the markets opened on Tuesday. The company posted $1.83 in earnings per share (EPS) on $18.8 billion in revenue. The…
Chris Lange